Standard BioTools Inc. (LAB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:19PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 848.65M |
| Enterprise Value | 831.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.67 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.82 |
| Enterprise Value/EBITDA | -15.28 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | 25.84% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 3.1600 |
| 52 Week Low 3 | 1.5700 |
| 50-Day Moving Average 3 | 2.6072 |
| 200-Day Moving Average 3 | 2.4258 |
Share Statistics
| Avg Vol (3 month) 3 | 2.34M |
| Avg Vol (10 day) 3 | 2.55M |
| Shares Outstanding 5 | 378.86M |
| Implied Shares Outstanding 6 | 378.86M |
| Float 8 | 50.42M |
| % Held by Insiders 1 | 0.65% |
| % Held by Institutions 1 | 58.09% |
| Shares Short (Apr 15, 2024) 4 | 11.28M |
| Short Ratio (Apr 15, 2024) 4 | 4.21 |
| Short % of Float (Apr 15, 2024) 4 | 3.12% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 2.98% |
| Shares Short (prior month Mar 15, 2024) 4 | 9.26M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2021 |
Profitability
| Profit Margin | -70.98% |
| Operating Margin (ttm) | -29.42% |
Management Effectiveness
| Return on Assets (ttm) | -9.39% |
| Return on Equity (ttm) | -22.74% |
Income Statement
| Revenue (ttm) | 126.76M |
| Revenue Per Share (ttm) | 0.95 |
| Quarterly Revenue Growth (yoy) | -14.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -80.12M |
| Net Income Avi to Common (ttm) | -43.96M |
| Diluted EPS (ttm) | -0.9400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.45M |
| Total Cash Per Share (mrq) | 0.37 |
| Total Debt (mrq) | 111.65M |
| Total Debt/Equity (mrq) | 118.03% |
| Current Ratio (mrq) | 4.51 |
| Book Value Per Share (mrq) | 1.23 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -97.28M |
| Levered Free Cash Flow (ttm) | -49.33M |
© 2024 Yahoo. All rights reserved.